Ecolab® Inc., Kleancheck Systems, LLC and Spartan Chemical Co., Inc. have resolved a patent infringement lawsuit brought by Ecolab and Kleancheck against Spartan. Ecolab exclusively licensed the DAZO® fluorescent marking gel technology from Kleancheck Systems, LLC, the development company founded by Dr. Philip Carling, a leading authority in infectious disease medicine. Ecolab offers the DAZO product as part of its EnCompass® Monitoring Program.Â
The EnCompass Monitoring Program uses the patented DAZO fluorescent marking gel to objectively measure thoroughness of disinfection cleaning on critical surfaces throughout the hospital. The cleaning outcomes data helps drive continuous improvement, provides compliance to current recommendations and reduces the risk of healthcare associated infections.
Ecolab and Kleancheck filed a patent infringement suit against Spartan on Aug. 30, 2013, alleging infringement of three U.S. Patents against Spartan's UVCheck® validation tool. Going forward, only Ecolabs EnCompass monitoring program will offer the patented fluorescent marking gel as part of an environmental monitoring program.
Source: Ecolab Inc.
Â
The Role of Environmental Hygiene in Preventing Antimicrobial Resistance
March 19th 2024Uncover the pivotal role of environmental hygiene in thwarting antimicrobial resistance (AMR) for infection prevention teams. Learn how rigorous cleaning protocols and advanced technologies enhance patient safety and combat AMR.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.